| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/14/2015 | CN104274423A 雷贝拉唑肠溶胶囊及其制备方法 Rabeprazole enteric-coated capsules and its preparation method |
| 01/14/2015 | CN104274420A 一种达沙替尼组合物及其制备方法 An imatinib composition and preparation method dasa |
| 01/14/2015 | CN104274413A 一种喜树碱类药物的纳米粒及其制备方法 One kind of nanoparticle drug camptothecin and its preparation method |
| 01/14/2015 | CN104274412A 一种含有替莫唑胺、其药学上可接受的盐或其他衍生物的药物制剂 Containing temozolomide, pharmaceutical formulations thereof, a pharmaceutically acceptable salt or other derivative thereof |
| 01/14/2015 | CN104274401A 一种基于hcpt-peg的喜树碱类药物的高载药纳米混悬剂及其制备方法 High drug loaded based hcpt-peg camptothecin drugs suspension and its preparation method |
| 01/14/2015 | CN104274390A 一种噻吗洛尔长效透皮制剂及其在血管瘤中的应用 A long-acting transdermal formulation of timolol and its application in hemangioma |
| 01/14/2015 | CN104273532A 具有抗癌作用的保健食品及其制备方法 Health foods have anti-cancer effects of its preparation method |
| 01/14/2015 | CN104273521A 一种基于糖基化酪蛋白的茶多酚纳米胶囊及其制备方法 Polyphenols nanocapsules based on a sugar base of casein and its preparation method |
| 01/14/2015 | CN104273229A 一种治疗脂肪瘤的香干及其制作方法 Xianggan a lipoma and production methods of treatment |
| 01/14/2015 | CN103861107B 一种药物组合物及其用途 A pharmaceutical composition and use thereof |
| 01/14/2015 | CN103610063B 龙根骨髓合剂及其制备方法 Rongen bone cement and its preparation method |
| 01/14/2015 | CN103601719B 2,2'-联吡啶-6,6'-二甲酰基-喹啉-2-胺衍生物及其制备方法与应用 2,2'-dimethyl-6,6'-bipyridine group - quinoline-2-amine derivatives and preparation method and application |
| 01/14/2015 | CN103553973B 邻硝基芳酰基β-氯乙基亚硝基脲类化合物及制备和用途 O-aroyl β- Ethylnitrosourea chlorine compounds and the preparation and use |
| 01/14/2015 | CN103432582B 一种rgd靶向卟啉聚合物纳米胶束的制备方法 A method for preparing the targeting of the porphyrin polymer micelles rgd |
| 01/14/2015 | CN103382190B 一类噻唑并环己烷类化合物、其制备方法和用途 A class thiazolo cyclohexane compounds, their preparation and use |
| 01/14/2015 | CN103319402B 二苯基硫脲类衍生物及其制备方法和应用 Diphenyl thiourea derivatives and its preparation method and application |
| 01/14/2015 | CN103242448B 一种全人源化抗pd-1单克隆抗体及其制备方法和应用 One kind of fully human anti-pd-1 monoclonal antibody and its preparation method and application |
| 01/14/2015 | CN103239467B 姬松茸多糖及其制备方法 Of ABM and its preparation method |
| 01/14/2015 | CN103183724B 多西紫杉醇共缀物的制备方法 A total of docetaxel conjugates preparation thereof |
| 01/14/2015 | CN103172819B 侧链带有氨基的可生物降解聚氨酯及其制备方法和用途 Bio-degradable polyurethane amino side chains with their preparation and use |
| 01/14/2015 | CN103145968B 叶酸偶联聚乙二醇单硬脂酸酯及其制备方法与应用 Folate-conjugated polyethylene glycol monostearate and its preparation method and application |
| 01/14/2015 | CN103142661B 一种桦褐孔菌水提精粉的制备方法 An aqueous extract of Inonotus powder preparation of |
| 01/14/2015 | CN103130723B 一种多聚(adp-核糖)聚合酶抑制剂 A multi-poly (adp- ribose) polymerase inhibitors |
| 01/14/2015 | CN103119031B 取代酰胺化合物 Substituted amide compounds |
| 01/14/2015 | CN103102392B 一种维甲酸诱导蛋白16n端多肽及其抗体的制备方法和应用 One kind of retinoic acid-inducible protein 16n terminal peptide antibody and its preparation method and application of |
| 01/14/2015 | CN102977114B 桑黄中单体成分-纤孔菌素a及其制备方法和应用 Phellinus monomer components - fiber hole streptozotocin a preparation method and application |
| 01/14/2015 | CN102973513B 智能纳米药物传递系统和制备方法及应用 Smart nano drug delivery systems and preparation method and application |
| 01/14/2015 | CN102961374B 一种化合物的应用以及stat3抑制剂 Application of a compound inhibitor and stat3 |
| 01/14/2015 | CN102949727B 靶向性抗肿瘤药物和基因共载载体材料及制备和应用 Anticancer drugs and gene targeting vector containing a total of material and preparation and application |
| 01/14/2015 | CN102887904B 2,3-二氧乙基-5-甲基-8,9-二甲氧基苯并菲啶衍生物及其制备方法和应用 The 2,3-ethyl-5-methyl-8,9-dimethoxy benzophenanthridine derivatives, preparation method and application |
| 01/14/2015 | CN102766122B 橙烷类衍生物及其用途 Orange alkyl derivatives and their use |
| 01/14/2015 | CN102746281B 4-1,2,3-三氮唑-香豆素衍生物及其制备方法和用途 4-1,2,3- triazole - coumarin derivatives and their preparation and use |
| 01/14/2015 | CN102471380B 抗FcRH5抗体和免疫偶联物及使用方法 Anti FcRH5 antibodies and immune conjugates and method of use |
| 01/14/2015 | CN102451474B 一种miRNA的抗肿瘤作用、实施方法及用途 Antitumor effect one miRNA, implementation methods and uses |
| 01/14/2015 | CN102388032B 作为ccr3拮抗剂的取代的哌啶 As ccr3 antagonists substituted piperidine |
| 01/14/2015 | CN102089001B 免疫诱导剂及癌的检测方法 Detection of immune-induced cancer agents |
| 01/13/2015 | US8933211 Growth factor isoform |
| 01/13/2015 | US8933103 Pyridone derivatives |
| 01/13/2015 | US8933086 Heteroaryl substituted pyrrolo[2,3-B]pyridines and pyrrolo[2,3-B]pyrimidines as Janus kinase inhibitors |
| 01/13/2015 | US8933085 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors |
| 01/13/2015 | US8933078 Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances |
| 01/13/2015 | US8933044 RNA interference mediating small RNA molecules |
| 01/13/2015 | US8933037 Methods involving PDGFRBETA inhibitors |
| 01/13/2015 | US8933027 Method of treating a disease or condition characterised by aberrant epithelial cell proliferation |
| 01/13/2015 | US8932649 Methods for treating a neoplastic disease in a subject using inorganic selenium-containing compounds |
| 01/13/2015 | US8932578 Cell and enzyme compositions for modulating ale acids, cholesterol and triglycerides |
| 01/13/2015 | CA2737355C Rapalogs, pharmaceutical compositions, preparation methods and uses thereof |
| 01/13/2015 | CA2730930C Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors |
| 01/13/2015 | CA2698079C A cell therapy method for the treatment of tumors |
| 01/13/2015 | CA2669187C Bicyclic heterocycles, drugs containing said compounds, the use thereof and methods for preparing same |
| 01/13/2015 | CA2668923C Use of tri-substituted glycerol compounds for the treatment of radiation injuries |
| 01/13/2015 | CA2596759C Local treatment of neurofibromas |
| 01/13/2015 | CA2591297C Il-7 variants with reduced immunogenicity |
| 01/13/2015 | CA2426601C Cyanoguanidine prodrugs |
| 01/08/2015 | WO2015003166A1 Substituted benzofuranyl and benzoxazolyl compounds and uses thereof |
| 01/08/2015 | WO2015003146A1 Boronic acid derivatives of resveratrol for activating deacetylase enzymes |
| 01/08/2015 | WO2015003128A1 Reducing adverse side effects of a compound by a neurotoxin |
| 01/08/2015 | WO2015003113A2 Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded rna |
| 01/08/2015 | WO2015002996A1 Precise delivery of therapeutic agents to cell mitochondria for anti-cancer therapy |
| 01/08/2015 | WO2015002969A1 Anticancer combinations |
| 01/08/2015 | WO2015002918A1 Ido inhibitors |
| 01/08/2015 | WO2015002766A1 Anti-tumor therapy |
| 01/08/2015 | WO2015002134A1 Cellular immunity inducing vaccine |
| 01/08/2015 | WO2015002119A1 Pyrazole-alcohol compound and pharmaceutical application therefor |
| 01/08/2015 | WO2015002118A1 Fluorene-amide compound and pharmaceutical application therefor |
| 01/08/2015 | WO2015002078A1 Novel boronic acid compound preparation |
| 01/08/2015 | WO2015001491A1 Pi3k protein kinase inhibitors, particularly delta and/or gamma inhibitors |
| 01/08/2015 | WO2015001436A1 Alkoxyamines for the treatment of cancers |
| 01/08/2015 | WO2015001348A1 Pyridazine derivatives as hedgehog pathway inhibitors |
| 01/08/2015 | WO2015001345A1 Methods for treating cancer |
| 01/08/2015 | WO2015001098A1 Crystalline forms of ponatinib hydrochloride |
| 01/08/2015 | WO2015001085A1 Humanized or chimeric cd3 antibodies |
| 01/08/2015 | WO2015001076A1 Novel gak modulators |
| 01/08/2015 | WO2015001021A1 Sulfoximine substituted 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives and their use as cdk9 kinase inhibitors |
| 01/08/2015 | WO2015000959A1 4-amino-6-aryl[2,3-d]pyrimidines for the inhibition of egfr tyrosine kinase |
| 01/08/2015 | WO2015000949A1 Heteroaryl pyridone and aza-pyridone amide compounds |
| 01/08/2015 | WO2015000947A1 Composition and use thereof for the treatment of tumor indications |
| 01/08/2015 | WO2015000946A1 Composition and use thereof for the treatment of benign and malign diseases |
| 01/08/2015 | WO2015000868A1 Novel compounds |
| 01/08/2015 | WO2015000411A1 Sulfated polygulonic acid polysaccharide or pharmaceutical salt thereof, preparation method therefor and use thereof |
| 01/08/2015 | WO2015000181A1 Novel recombinant fusion protein, preparation method therefor and use thereof |
| 01/08/2015 | WO2015000062A1 Egfr antibody conjugates |
| 01/08/2015 | WO2015000012A1 Radiolabelled material |
| 01/08/2015 | WO2014153226A9 Arginine methyltransferase inhibitors and uses thereof |
| 01/08/2015 | US20150011732 Polymer conjugates of interferon beta-1a and uses |
| 01/08/2015 | US20150011514 Celecoxib Compositions |
| 01/08/2015 | US20150010946 Polynucleotides encoding zcytor17 ligand antibodies |
| 01/08/2015 | US20150010587 Kidney-specific tumor vaccine directed against kidney tumor antigen g-250 |
| 01/08/2015 | US20150010576 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/08/2015 | US20150010570 Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factor |
| 01/08/2015 | US20150010554 Methods for treating interleukin-6 related diseases |
| 01/08/2015 | US20150010551 Compositions and Methods of Treating Tumors |
| 01/08/2015 | DE202014006418U1 Canniflavon: Zytotoxizität und Wirkmechanismen in Krebszellen Canniflavon: Cytotoxicity and mechanisms of action in cancer cells |
| 01/07/2015 | EP2821406A1 Novel piperidine compound or salt thereof |
| 01/07/2015 | EP2821402A1 Nitrogen-containing aromatic heterocyclic compound |
| 01/07/2015 | EP2821107A1 Composition and use thereof for the treatment of benign and malign diseases |
| 01/07/2015 | EP2821106A1 Composition and use thereof for the treatment of tumor indications |
| 01/07/2015 | EP2821079A1 Body cavity effusion suppressant |
| 01/07/2015 | EP2821071A1 Compounds for breast cancer treatment |
| 01/07/2015 | EP2820148A1 Screening assays for identifying and validating agents that target cancer stem cells |